Asia
-
INTERPHEX Asia
INTERPHEX Asia, part of the worldwide INTERPHEX family of events, is one single platform that underlines all pharmaceutical and biopharmaceutical technologies, services and innovations to the right blend of industry professionals.
Asia | 19 April 2012
-
Pharmaceutical companies from Japan, India and China are amongst Asia Pacific’s most innovative
Pharmaceutical companies from Japan, India and China were among Asia Pacific’s leading innovators last year according to one of two reports released by Thomson Reuters, which provide new insights into global patent and trademark trends throughout 2011.
Asia | 28 March 2012
-
Bayer plans further expansion in Asia
The Bayer Group plans to further expand its production, distribution network and research activities in Asia and considerably increase its sales in the region in the coming years.
Asia | 13 February 2012
-
ICON Development Solutions appoints general manager of Asia Pacific
ICON announced that its development solutions division has appointed Dr Daniel Tang as general manager, Asia Pacific. Dr Tang will lead the development of ICON’s early phase activities across the region, including bioanalytical laboratory services, and the development of strong links with key opinion leaders for early phase clinical testing.
Asia | 12 December 2011
-
Abbott honored with Asian CSR award for leadership in science education
Abbott science education programs advance science learning for children in Asia and around the world.
Asia | 24 October 2011
-
Bio-Images Group expands its presence in Asia Pacific
To exhibit at AusBiotech 2011 in Adelaide, South Australia this October.
Asia | 10 October 2011
-
India generics companies lead pharmaceutical innovation in Asia Pacific
Thomson Reuters Asia Pacific R&D Factbook details significant increases in innovation investment and development of novel drug pipelines.
Asia | 30 September 2011
-
Nycomed and Almirall announce a licensing agreement for ebastine in China and other key Southeast Asia markets
• With this agreement, Almirall extends the global reach of the product, present now in more than 30 countries worldwide.
Asia | 29 September 2011
-
Japan and China dominate Asian active pharmaceutical ingredients market
The market for active pharmaceutical ingredients (APIs) is highest in the US, followed by Europe and Asia Pacific – the geographic market reporting fastest growth. According to a new report on companiesandmarkets.com, revenue growth in the Asia-Pac…
Asia | 14 July 2011
-
Joining forces to beat cancer in Asia
Three of the world’s biggest pharma companies are joining forces to try and combat Asia’s ‘cancer epidemic’.
Asia | 04 July 2011
